Addressing liver diseases, including viral hepatitis, non-alcoholic fatty liver disease (NAFLD), and liver cirrhosis, this session examines epidemiology, risk factors, and therapeutic strategies. Discussions will cover liver transplantation advancements, disease progression models, and interventions to mitigate liver damage. Liver diseases represent a significant global health burden, requiring integrated approaches involving hepatologists, transplant surgeons, and researchers. By discussing liver disease prevention, early detection, and management strategies, this session aims to improve liver health outcomes, reduce disease prevalence, and enhance healthcare systems' capacity to address liver-related challenges effectively.